申请人:Cancer Targeted Technology
公开号:US10166301B2
公开(公告)日:2019-01-01
Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.
本文所定义的化合物可用于:(1) 检测和/或识别呈现 PSMA 的细胞的诊断方法;(2) 由本发明化合物和药学上可接受的稀释剂组成的组合物;(3) 前列腺癌细胞成像方法。